Trellus Health (TRLS) Share Price

Health Care Sector


NOTE: This is based on 0 open tips for Trellus Health (TRLS)


Trellus Health (TRLS)
Latest Quote Price

0.58p

Trellus Health (TRLS)
Price Change (%)

3.42%


Latest Bid : 0.55p Latest Ask : 0.60p
High Today : 0.60p Low Today : 0.55p
This Years High : 5.50p This Years Low : 0.55p
Volume : 843,532 MKT Cap : £0.97M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

Trellus Health (TRLS) Overview

Trellus Health is commercialising the provision of digital chronic condition management solutions for employers and health plans that utilise the scientifically validated GRITT™ resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate™ to coordinate and deliver care remotely via telemedicine. The Company is initially focused on Inflammatory Bowel Diseases (IBD), which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis, but considers its approach to have potential utility and demand across many chronic conditions.


You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Trellus Health (TRLS) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : 0.55p Latest Ask : 0.60p
High Today : 0.60p Low Today : 0.55p
This Years High : 5.50p This Years Low : 0.55p
Volume : 843,532 MKT Cap : £0.97M

Trellus Health Overview

Trellus Health is commercialising the provision of digital chronic condition management solutions for employers and health plans that utilise the scientifically validated GRITT™ resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate™ to coordinate and deliver care remotely via telemedicine. The Company is initially focused on Inflammatory Bowel Diseases (IBD), which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis, but considers its approach to have potential utility and demand across many chronic conditions.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.